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Abstract
microRNA-155 (miR155) is a central regulator of immune responses that is induced by inflammatory mediators. Although
miR155 is considered to be a pro-inflammatory microRNA, in vitro reports show anti-inflammatory effects in lipid-loaded
cells. In this study we examined the role of miR155 in atherosclerosis in vivo using bone marrow transplantation from
miR155 deficient or wildtype mice to hyperlipidemic mice. Hematopoietic deficiency of miR155 enhanced atherosclerotic
plaque development and decreased plaque stability, as evidenced by increased myeloid inflammatory cell recruitment to
the plaque. The increased inflammatory state was mirrored by a decrease in circulating CD4
+CD25
+FoxP3
+ regulatory T cells,
and an increase in granulocytes (CD11b
+Ly6G
+) in blood of miR155
2/2 transplanted mice. Moreover, we show for the first
time a crucial role of miR155 in monocyte subset differentiation, since hematopoietic deficiency of miR155 increases the
‘inflammatory’ monocyte subset (CD11b
+Ly6G
2Ly6C
hi) and reduces ‘resident’ monocytes (CD11b
+Ly6G
2Ly6C
low) in the
circulation. Furthermore, cytokine production by resident peritoneal macrophages of miR155
2/2 transplanted
hyperlipidemic mice was skewed towards a more pro-inflammatory state since anti-inflammatory IL-10 production was
reduced. In conclusion, in this hyperlipidemic mouse model miR155 acts as an anti-inflammatory, atheroprotective
microRNA. Additionally, besides a known role in lymphoid cell development, we show a crucial role of miR155 in myeloid
lineage differentiation.
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Introduction
Atherosclerosis is a chronic inflammatory disease characterized
by the accumulation of lipids and inflammatory cells in the vessel
wall. Upon injury, monocytes are recruited to the vessel wall,
where they differentiate into macrophages, scavenge lipids and
become foam cells. Macrophages are a major source of
inflammatory mediators in atherosclerotic lesions, contributing
to the chronic nature of the inflammatory response. This chronic
inflammatory response not only includes innate immune responses
by myeloid cells but also adaptive immune responses by T- and B-
cells.
MicroRNAs are small non-coding RNAs that negatively
regulate expression of complementary genes by targeting messen-
ger RNAs. Various microRNAs have been associated with
inflammation and cardiovascular disease [1]. In this study we
focus on microRNA-155 (miR155), a central regulator of immune
responses that is highly expressed in activated immune cells [2]
and various autoimmune inflammatory diseases [3–5]. miR155
expression in myeloid cells is induced by various inflammatory
signals, including lipopolysaccharide (LPS), interferon-b and
tumor necrosis factor [6]. It is considered to be a pro-inflammatory
miRNA, mainly since one of its major targets is Suppressor of
Cytokine Signaling (SOCS) 1, an endogenous inhibitor of
inflammatory signaling [7]. Studies using miR155 deficient mice
have shown defective B-and T-cell immunity, as well as impaired
antigen-presenting functions of dendritic cells [3,8,9].
Besides inflammatory stimuli, exposure to oxidized low density
lipoproteins (oxLDL) was shown to induce miR155 expression in
human THP-1 macrophages [10]. oxLDL uptake and foam cell
formation in these cells was increased when miR155 was inhibited
and this was associated with upregulation of scavenger receptors
[11,12]. Interestingly, miR155 inhibition in these foam cells
promoted NF-kB activity and the release of several pro-
inflammatory cytokines [12], suggesting an anti-inflammatory
rather than pro-inflammatory role of miR155 in atherosclerotic
conditions. Most studies on the role of miR155 however have been
performed in vitro, lacking the interaction and cross-talk with other
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35877cells. In this study we used miR155 deficient mice to study the
exact role of miR155 in atherosclerosis development and plaque
stability. We show that hematopoietic miR155 deficiency in
hyperlipidemic mice increases atherosclerotic plaque burden and
augments the inflammatory state in these mice.
Results
Hematopoietic deficiency of miR155 leads to larger, more
advanced atherosclerotic lesions in LDLR
2/2 mice
Considering the key role of miR155 in regulating inflammation
and immunity and the chronic inflammatory nature of athero-
sclerotic plaques, we investigated the effect of hematopoietic
absence of miR155 on atherosclerosis development. Therefore, we
reconstituted bone marrow from miR155
2/2 mice or their
wildtype controls to lethally irradiated LDLR
2/2 mice. Five
weeks after reconstitution, mice were placed on a high cholesterol
(HC) diet for 10 weeks after which atherosclerosis development
was assessed in the aortic root. Overall chimerism determination
showed similar (.95%) repopulation for both genotypes and no
differences between groups were found in body weight
(21.760.4 g for wildtype vs 21.760.3 g for miR155
2/2 trans-
planted mice). Although plasma cholesterol levels at the start of the
diet were slightly reduced in the miR1552/2 transplanted mice
(10.7360.23 mmol/L for wildtype vs 9.7960.38 mmol/L for
miR155
2/2, p=0.04), no significant differences were found in
either plasma cholesterol or triglyceride levels after HC diet
feeding (figure 1). The slight reduction in plasma cholesterol before
HC diet feeding was found in all lipoprotein fractions (i.e. VLDL,
LDL and HDL, Figure S1A), indicating no shift in lipoprotein
distribution between genotypes. No differences in cholesterol in
these fractions were found after HC diet feeding for 10 weeks
(Figure S1B).
Quantification of the atherosclerotic lesion area in the aortic
root revealed a small, but significant 18% increase in lesion area in
the miR155
2/2 transplanted mice compared to wildtype trans-
planted animals (figure 2A–C, p=0.04). Furthermore, plaque
classification revealed that plaques in miR155
2/2 transplanted
mice were more advanced compared to wildtype transplanted
mice (figure 2D, Chi-square test p=0.046).
Hematopoietic deficiency of miR155 leads to more
inflammatory atherosclerotic lesions
Atherosclerotic lesions were further examined by routine
pathological examination for their composition, i.e. collagen
content, necrosis, foam cell content, amount of inflammatory
cells. Whereas no differences were found in collagen, apoptosis,
necrosis or foam cell content, the number of inflammatory cells
within the atherosclerotic lesion, adhering to the plaque or present
in the adventitia was found to be increased (Figure 3A–C and
Figure S2). Immunohistochemical quantifications revealed that
this increase in inflammatory cells was mainly attributable to an
increase in neutrophils (Figure 3D, p,0.05) and macrophage
recruitment (Figure 3E, p,0.05), whereas the number of T cells in
miR155
2/2 transplanted mice was decreased compared to
controls (Figure 3F, p=0.05). Although we did not find a
difference in relative monocyte/macrophage content between
groups (Figure 3C), we found a significant increase in the number
of newly recruited macrophages (ERMP58
+, Figure 3E, p,0.05)
[13]. In wildtype transplanted mice newly recruited small
macrophages were mainly found in moderate lesion types and
recruitment decreased when plaques progressed to advanced
lesions. In contrast, in miR155
2/2 transplanted mice we found
more recruitment of new macrophages in advanced lesions than in
earlier stages of the disease (Figure S3, p=0.06). This may imply
that while in wildtype lesions progression by monocyte recruitment
slows down and stabilizes at a certain stage, in the miR155
2/2
transplanted mice advanced lesions continue to attract circulating
monocytes.
Since miR155 has been implicated in in vitro oxLDL uptake by
human THP-1 macrophages [11,12], we investigated in vivo foam
cell formation by Oil Red O lipid staining of peritoneal
macrophages after HC diet feeding [14]. We did not find any
difference in the number of peritoneal foam cells between
miR155
2/2 or wildtype transplanted mice (Fig. S4), which
confirmed our findings in the atherosclerotic lesions, where
pathological scoring showed that foam cell content was also
similar in both groups (Figure 3A).
Together these data show that miR155 conveys atheroprotec-
tive effects by limiting leukocyte recruitment to the atherosclerotic
lesions rather than acting as a pro-inflammatory microRNA in this
hyperlipidemic milieu.
Figure 1. Plasma lipid levels of mice transplanted with either miR155
2/2 or wildtype bone marrow. Cholesterol (A) and Triglyceride (B)
levels measured before the start of HC diet (0 weeks of diet), after 5 weeks of diet and upon sacrifice of the mice (10 weeks of diet). * p,0.05, n=20/
group.
doi:10.1371/journal.pone.0035877.g001
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reflected in circulating leukocytes and peritoneal cells
To determine whether the pro-inflammatory effects of hema-
topoietic deficiency of miR155 in the transplanted LDLR
2/2
mice on HC diet are also reflected systemically, we performed
FACS analyses on circulating leukocytes. In the lymphoid lineage,
we found a small, but significant decrease in the number of B-cells
(p=0.02) and increase in CD3
+ T cells (p=0.01), although neither
CD4
+ T-helper cell nor CD8
+ cytotoxic T cell subsets were
affected by miR155 deficiency (Figure 4A). Interestingly, in
agreement with findings of others under normolipidemic condi-
tions [8], miR155 deficiency in hyperlipidemic mice decreased
regulatory T cells (both CD4
+CD25
+ and CD25
+FoxP3
+ Treg
subsets) in the blood (Figure 4B, p,0.001).
Concerning the myeloid lineage, miR155 deficiency significant-
ly increased the number of neutrophils (CD11b
+Ly6G
+,
Figure 4C–E, p,0.01), reflecting the increased neutrophil content
of the atherosclerotic lesions of miR155
2/2 transplanted mice
compared to wildtypes (Figure 3B). Remarkably, while circulating
monocytes (CD11b
+Ly6G
2) was similar in both groups, miR155
deficiency in hyperlipidemic mice skewed the monocyte popula-
tions toward more pro-inflammatory (Ly6C
hi) subsets (Figure 4C,
D and F, p,0.001). To investigate whether miR155 is also
important in the development of different macrophage subsets in
vivo, we isolated resident peritoneal macrophages from the
hyperlipidemic mice and analyzed inflammatory cytokine produc-
tion after in vitro LPS stimulation by intracellular cytokine staining.
Interestingly, although production of pro-inflammatory IL-12 was
not affected, miR155 deficiency skewed macrophages towards a
more pro-inflammatory phenotype by reducing the production of
anti-inflammatory IL-10 (Figure 5, p,0.001).
miR155 deficiency leads to increased pro-inflammatory
macrophage responses in hyperlipidemic conditions only
To elucidate the mechanisms behind these pro-inflammatory
rather than the expected anti-inflammatory effects of miR155
deficiency, we isolated RNA directly from resident peritoneal cells
from the hyperlipidemic wildtype and miR155
2/2 transplanted
mice and analyzed mRNA expression of SOCS-1, cytokines and
NFkB-related genes. Whereas no differences were found between
wildtypes and miR155
2/2 cells in IL-12, TNF, MyD88 or IkBa
(data not shown), we found a significant reduction in IL-10
expression in miR155
2/2 transplanted mice (Figure 6A), con-
firming our results in resident, hyperlipidemic peritoneal macro-
phages (shown in Figure 5). Furthermore, we found an increase in
pro-inflammatory IL-6 mRNA expression and no difference in
SOCS-1 mRNA (Figure 6B and C, respectively).
We next investigated whether the pro-inflammatory effects of
miR155 deficiency in our setting may be a direct result of the
hyperlipidemia in HC diet fed LDLR
2/2 mice. Therefore, we
performed in vitro experiments with wildtype or miR155
2/2 bone
marrow derived macrophages that were loaded with oxLDL to
Figure 2. Hematopoietic deficiency of miR155 promotes atherosclerotic lesion development in LDLR
2/2 mice. Representative pictures
of toluidine blue-stained sections of the aortic root of wildtype (A) and miR155
2/2 (B) transplanted mice, magnification 406. Hematopoietic miR155
deficiency increases plaque area (C) and promotes plaque progression towards more advanced lesions (D, Chi square test p,0.05). * p,0.05, n=14
wildtypes and 19 miR1552/2 mice.
doi:10.1371/journal.pone.0035877.g002
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cytokines and NFkB-signaling genes were determined in oxLDL-
loaded or non-lipid loaded macrophages after 3 hrs of LPS
stimulation. As expected miR155 deficiency increased SOCS-1
expression in non-lipid loaded macrophages compared to wildtype
macrophages (figure S5A). Interestingly, oxLDL loaded macro-
phages produce less SOCS-1 and miR155 deficiency in these foam
cells fails to induce SOCS-1 expression. Whereas miR155
deficiency did not affect TNF, IL-6, IL-12, MyD88 or IkBa
mRNA expression in either non-lipid loaded or oxLDL-loaded
macrophages, IL-10 production was diminished in miR155
2/2
foam cells, but not in non-lipid loaded macrophages (figure S5B).
These data support our hypothesis that miR155 deficiency has
more pro-inflammatory effects in hyperlipidemic, lipid loaded
conditions rather than its anti-inflammatory effects under normal
conditions.
Figure 3. Hematopoietic deficiency of miR155 enhances inflammation in atherosclerotic lesions. (A) Pathological examination of
collagen, necrosis, foam cells, inflammatory cells, monocyte adhesion to the plaque and adventitial influx. AU: arbitrary units. (B) collagen content
stained by Sirius red staining, (C) Monocyte/macrophage area stained by moma-2, (D) Neutrophil numbers stained by NIMP, (E) Newly recruited
macrophages identified by ERMP58 and (F) T cell numbers stained by KT-3 antibody (directed against CD3). Arrowheads indicate positively stained
cells. *p,0.05, n=14 wildtypes and 19 miR1552/2 mice.
doi:10.1371/journal.pone.0035877.g003
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This study is the first to show that miR155 has anti-
inflammatory and atheroprotective effects in hyperlipidemic mice.
Atherosclerotic lesions of miR155
2/2 transplanted mice were not
only larger, but also contained more inflammatory cells than those
of control mice. The increased inflammation in atherosclerotic
lesions was mirrored by increased numbers of circulating
CD11b
+Ly6G
+ granulocytes and CD11b
+Ly6C
hi inflammatory
monocytes, while CD4
+CD25
+FoxP3
+ Treg cells were decreased in
miR155
2/2 transplanted mice. Similar decreases in Treg cells were
reported by others in miR155
2/2 mice under normolipidemic
conditions, although Treg function appeared to be normal [8].
Moreover, production of the anti-inflammatory cytokine IL-10
was reduced in peritoneal macrophages isolated from hyperlipid-
emic miR155
2/2 mice as well as in bone marrow derived
miR155
2/2 macrophages that were loaded with oxLDL in vitro.
Moreover, miR155 deficiency leads to an increase in SOCS-1
expression in non-lipid loaded macrophages, but not in foam cells.
Although miR155 is generally considered to be a pro-
inflammatory microRNA, by suppressing SOCS1, this in vivo
study strongly indicates an opposite role in hyperlipidemic mice.
Indeed, in unstimulated resident peritoneal cells from the in vivo
bone marrow transplantation experiment we found no increase in
SOCS-1 expression in miR155
2/2 transplanted animals com-
pared to controls. Furthermore, in these cells we found a reduction
in IL-10 mRNA expression, in line with the reduced IL-10 protein
expression in peritoneal macrophages from this in vivo experiment
after in vitro LPS stimulation. Direct evidence supporting our
hypothesis that in hyperlipidemia miR155 exerts opposite effects
were demonstrated by our in vitro study with wildtype and
miR155
2/2 bone marrow derived macrophages that were either
oxLDL-loaded or not. Here we showed that miR155 deficiency
increases SOCS-1 expression in non-lipid loaded macrophages,
Figure 4. Pro-inflammatory blood leukocyte profile in hematopoietic miR155 deficient mice. (A) Blood lymphocytes profile. B220 for B
cells, CD3 for T cells, CD4 T-helper cells and CD8 for cytotoxic T cells. (B) Regulatory T cells identified by CD4
+CD25
+ and CD25
+FoxP3
+ staining.
Representative examples of circulating myeloid cells in wildtype transplanted (C) and miR155
2/2 transplanted (D) mice. (E) Number of circulating
granulocytes (CD11b
+Ly6G
+) and monocytes (CD11b
+Ly6G
2), subdivided in Ly6C
hi (inflammatory), Ly6C
low (resident) and Ly6C
med monocytes (F).
*p,0.05, n=10/group.
doi:10.1371/journal.pone.0035877.g004
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only reduced in oxLDL-loaded macrophages deficient in miR155.
Such anti-inflammatory function is in agreement with two in vitro
studies showing that miR155 in lipid-loaded macrophages actually
dampens their activation. Huang et al showed that antisense
oligonucleotide silencing of endogenous miR155 in human THP-1
macrophages treated with oxLDL promoted the release of pro-
inflammatory cytokines, i.e. IL-6, IL-8 and TNF-a [12]. This
enhanced inflammatory response was accompanied by upregula-
tion of MyD88 protein expression and NFkB translocation, a
finding we could not confirm, at least not on mRNA levels. In line
with the study of Huang et al and the current study, Chen et al.
showed that miR155 inhibition also upregulated the adhesion
molecules ICAM-1 and VCAM-1 in PMA-differentiated and
oxLDL treated THP-1 cells [11]. Interestingly, both studies
reported an increased scavenger receptor expression and increased
oxLDL uptake by these cells. This finding however, could not be
confirmed in our in vivo study, since no differences were found in
lipid uptake by peritoneal macrophages or foam cell formation in
the plaque.
The last decade, increasing evidence has shown large plasticity
and heterogeneity in both monocytes and macrophage popula-
tions [15,16]. In mice we mainly distinguish 2 monocyte subsets,
i.e. CD11b
+/Ly6C
hi ‘inflammatory’ monocytes that are rapidly
recruited to sites of inflammation and give rise to inflammatory
macrophages and dendritic cells, and CD11b
+/Ly6C
low ‘resident’
or ‘patrolling’ monocytes that can enter the tissues under steady
state conditions. Similarly we can distinguish various macrophage
subsets, i.e. pro-inflammatory M1 macrophages and anti-inflam-
matory M2 macrophages [17]. M1 macrophages are induced by
bacterial compounds or pro-inflammatory cytokines like IFNc and
have the capacity to increase and sustain the ongoing inflamma-
tory response and to clear the system of bacterial, viral and fungal
infections via production of inflammation-promoting mediators
(e.g. IL-12). In view of their pro-inflammatory nature, Ly6C
hi
inflammatory monocytes and M1 macrophages are considered to
be pro-atherogenic. M2 macrophages, on the other hand, are
induced by anti-inflammatory cytokines like IL4/13 and IL10 and
have been shown to promote tissue repair and healing. M2
macrophages produce anti-inflammatory mediators such as IL-10,
a cytokine well known to be atheroprotective [18]. To our
knowledge this study is the first report of a role for miR155 in
differentiation of monocyte and macrophage subsets. Besides an
increase of the inflammatory Ly6C
hi monocyte subset in the
circulation, miR155 deficiency also skewed macrophages in the
peritoneal cavity towards a more pro-inflammatory phenotype, as
their production of anti-inflammatory IL-10 was reduced.
Interestingly, Ding et al showed the miR155 target SOCS1 to be
an important inhibitor of IL-10 signaling [19]. Furthermore,
recently a role of SOCS1 in macrophage polarization has been
described in vitro [20]. In this study SOCS1 was shown not only to
be important in controlling polarization towards the anti-
inflammatory M2 macrophage phenotype, but also to regulate
pro-inflammatory M1 macrophage responses e.g. by restricting IL-
10 production. In line with these findings, our data may suggest a
role for miR155 in macrophage polarization in vivo.
Figure 5. Hematopoietic miR155 deficiency decreases anti-inflammatory IL-10 production in peritoneal macrophages. IL-10 and IL-12
production by peritoneal macrophages of wildtype transplanted (A) and miR155
2/2 transplanted (B) mice. Production of anti-inflammatory IL-10 in
peritoneal macrophages of miR155
2/2 transplanted mice is reduced (C). *p,0.05, n=10/group.
doi:10.1371/journal.pone.0035877.g005
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role of miR155 and anti-inflammatory effects of miR155 in vivo in
hyperlipidemic conditions. The increase of neutrophils and newly
recruited macrophages in the atherosclerotic lesions was mirrored
by a more pro-inflammatory blood leukocyte profile as evidenced
by increased granulocytes and inflammatory monocytes, as well as
a decrease in regulatory T-cells. Moreover, we not only showed an
increase in circulating inflammatory monocytes but also decreased
anti-inflammatory cytokine production by peritoneal macrophag-
es, providing evidence for a role of miR155 in monocyte and
macrophage subset differentiation.
Methods
Bone marrow transplantation
All animal experiments were approved by the DierExperimen-
ten Commisie (DEC) of the Maastricht University (permit number
2009-168). Ten to twelve week old male miR155
2/2 or wildtype
C57Bl/6J mice were used as donor mice (n=5 per group). Forty
female LDLR
2/2 mice (10–12 weeks) backcrossed onto a C57Bl6
background for more than 10 generations were obtained from in-
house breeding. Bone marrow transplantations were performed as
described elsewhere [21]. In short, LDLR
2/2 mice were lethally
irradiated with 6 Gy the day before and the day of transplantation.
Mice were transplanted with 5610
6 bone marrow cells from
wildtype or miR155
2/2 mice. Five weeks after transplantation
mice were put on a 16% fat, 0.15% cholesterol diet without
cholate (Western type diet #4021.13, Hope Farms, The Nether-
lands). Before the onset of the high cholesterol diet, mice were
fasted for 4 hours, after which blood was drawn from the tail vein
for lipid analysis, and chimerism determination. Additional blood
analysis was performed at 5 and 10 weeks of HC diet. The
chimerism in transplanted mice was determined on blood DNA as
described previously [22].
Morphometry and immunohistochemistry murine tissues
After 10 weeks of Western-type diet feeding, mice were
anesthetized and euthanized. Mouse hearts were dissected and
snap frozen in OCT. Atherosclerosis development (lesion size and
classification) was determined as described elsewhere [22]. Plaques
were classified as early, moderate and advanced lesions. Early
lesions consist of foam cells, but without formation of a necrotic
core. Moderate lesions contain a fibrotic cap and often a necrotic
core, but no macrophage infiltration into the media. Advanced
lesions show (deep) infiltration of macrophages into the media and
may contain elastic lamina degradation and more severe necrosis
and fibrosis. Serial sections (7 mm) of the aortic root were cut and
toluidine blue stained for morphometrical analysis and routine
pathological examination for their composition, i.e. collagen
content, necrosis, foam cell content, amount of inflammatory
cells. TUNEL staining was used for detection of apoptotic cells.
Sirius red staining was performed for the detection of collagen.
Furthermore, sections were stained with Moma2 (a gift from G.
Kraal) for the quantification of monocytes and macrophages,
ERMP58 for early infiltrating macrophages (a gift from P.
Leenen), KT3 for the detection of CD3
+ T-cells and NIMP-1
Figure 6. Pro-inflammatory effects of miR155 deficiency specifically in resident, hyperlipidemic peritoneal cells. mRNA was isolated
from resident peritoneal cells obtained from wildtype or miR155
2/2 transplanted mice after 10 weeks of HC diet feeding. miR155 deficiency
decreases IL-10 mRNA expression (A), while increasing IL-6 mRNA expression (B) in these hyperlipidemic peritoneal cells. No differences were found
between genotypes on SOCS-1 mRNA expression (C). *p,0.05, n=9–10/group.
doi:10.1371/journal.pone.0035877.g006
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purified).
Lipid analysis
For size fractionation of lipoproteins, 60 ml of pooled plasma
(three pools of 3 mice per group) was separated using an AKTA
Basic chromotography system with a Superose 6PC 3.2/30
column (Amersham Biosciences, Roosendaal, The Netherlands).
Total plasma cholesterol and triglyceride levels as well as
cholesterol in lipoprotein fractions were determined using
standard enzymatic kits according to manufacturer’s protocols
(Sigma-Aldrich, Zwijndrecht, the Netherlands).
Flow cytometry analysis (FACS)
Blood leukocyte analysis was performed by FACS analysis. To
discriminate between T-cells, B-cells, granulocytes and monocytes,
cells were stained with either anti-CD3 (Ebioscience, clone 145-
C11), CD45R/B220 (Ebioscience, clone RA3-6B2), Ly6G (BD,
clone 1A8) or CD11b (BD, clone M1/70). Monocyte subsets were
further delineated using Ly6C (Miltenyi, 1G7.G10) into inflam-
matory (Ly6C
hi) and resident monocytes (Ly6C
2). Furthermore,
T-cell subsets were defined by CD4 (T-helper cells) (BD, clone
RM4-5), CD8 (Cytotoxic T cells) (Ebiosciences, clone 53-6.7) and
CD25 (Ebiosciencs, clone PC61.5) combined with FoxP3
(regulatory T cells) (Ebiosciences, clone FJK-16s).
Resident peritoneal macrophages were obtained by flushing the
peritoneal cavity with ice-cold PBS followed by culturing in RPMI
1640 culture medium containing 10% FCS, penicillin (100 U/ml),
streptomycin (100 ug/ml), and L-glutamine 2 mM (all GIBCO
Invitrogen, Breda, The Netherlands). After overnight attachment,
floating cells were removed while attached cells were activated by
10 ng/ml LPS in combination with GolgiSTOP (BD) for 6 hrs.
Cells were subsequently collected and stained using F4/80-FITC
(AbD serotec, clone CI:A31) and CD19-PERCPcy5.5 (Ebios-
ciences, clone 1D3) to discriminate between macrophages and B-
cells respectively. To study intracellular IL-10 and IL-12 cytokine
levels, cells were fixated using BD cytofix/cytoperm, permeabi-
lized (BD perm/wash) and subsequently stained with IL-10-APC
(Ebioscience, clone Jes5-16E3) and IL-12-PE (Ebioscience, clone
C17.8). All flow cytometry measurements were performed by a
FACS CANTO II (BD) followed by data analysis using FACSdiva
software.
In vivo peritoneal foam cell analysis
Peritoneal macrophages were collected as described above and
stained for lipids using Oil Red O. The percentage of cells
containing at least 2 lipid droplets was measured by counting at
least 100 macrophages by light microscopy at 4006magnification.
Bone marrow derived macrophage isolation and culture
Bone marrow cells were isolated from femurs and tibiae of
either wildtype or miR155
2/2 mice. Cells were cultured in RPMI-
1640 (GIBCO Invitrogen, Breda, the Netherlands) with 10% heat-
inactivated fetal calf serum (Bodinco B.V. Alkmaar, the Nether-
lands), penicillin (100 U/ml), streptomycin (100 mg/ml) and L-
glutamine 2 mM (all GIBCO Invitrogen, Breda, the Netherlands)
supplemented with 15% L929-conditioned medium (LCM) for 8–
9 days to generate bone marrow-derived macrophages, as
described previously [22].
Macrophages were seeded at 350000 cells per well in 24 wells
plates and incubated 24 hrs with 0–25 mg/ml oxLDL (Intracel
Resources, Frederick, Maryland, USA), followed by 3 hrs
stimulation with 0–10 ng/ml LPS.
Gene expression
RNA was isolated from resident peritoneal cells from the bone
marrow transplantation experiment or from bone marrow
derived macrophages with the High Pure RNA Isolation Kit
(Roche, Basel, Switzerland). 500 ng total RNA was reverse
transcribed using the iScript cDNA Synthesis Kit (BioRad,
Veenendaal, the Netherlands). Quantitative PCR was performed
using 10 ng cDNA, 300 nM of each primer, and SensiMix
(Quantace-Bioline, London, UK) in a total volume of 20 ml. All
gene expression levels were corrected for cyclophilin A, b-actin
and GAPDH as housekeeping genes. Primer sequences are
available upon request.
Statistical analysis
Data are presented as mean 6 the standard error of the mean
(SEM). All statistical analyses were performed using the Prism
program (GraphPad Software Inc, San Diego, CA). The statistical
significance of differences was evaluated with the Student’s t-test.
Significance was accepted at the level of p,0.05.
Supporting Information
Figure S1 Representative examples of plasma VLDL,
LDL and HDL cholesterol levels. Cholesterol levels in all
fractions were reduced in miR155
2/2 transplanted mice before
the start of HC diet feeding (A). No differences were found after 10
weeks of HC diet (B). n=3 pools of 3 mice per group.
(TIF)
Figure S2 Apoptosis is not affected by miR155 deficien-
cy. No differences were found in number of apoptotic cells in the
atherosclerotic lesions as quantified by TUNEL staining. n=11
wildtypes and 12 miR1552/2 mice.
(TIF)
Figure S3 Persisting monocyte recruitment in advanced
lesions of miR155
2/2 transplanted mice. Increased
number of newly recruited macrophages (ERMP58
+, p=0.06) in
advanced atherosclerotic lesions, indicating persistence of mono-
cyte recruitment, in miR155
2/2 transplanted mice compared to
wildtype transplanted mice. n=20/group.
(TIF)
Figure S4 Hematopoietic miR155 deficiency does not
influence in vivo lipid uptake by peritoneal macrophag-
es. The percentage of Oil red O stained cells containing at least 2
lipid droplets was counted at 4006magnification. n=10/group.
(TIF)
Figure S5 Pro-inflammatory effects of miR155 deficien-
cy specifically in foam cells. Wildtype or miR155
2/2 bone
marrow derived macrophages (pools from 2 mice/group) were
loaded with 0–25 mg/ml oxLDL for 24 hrs followed by 3 hrs LPS
stimulation (10 ng/ml). miR155 deficiency leads to an increase in
SOCS-1 mRNA expression in non-lipid loaded macrophages, but
not in foam cells (A). IL-10 mRNA production is reduced in
miR155
2/2 foam cells, but not in non-lipid loaded macrophages
(B). *p,0.05 miR155
2/2 vs wildtype, treatments in triplicate.
(TIF)
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